← Back to home

HIV-infected participants with latent TB infection in high TB burden country

Clinical trials for HIV-infected participants with latent TB infection in high TB burden country explained in plain language.

Never miss a new study

Get alerted when new HIV-infected participants with latent TB infection in high TB burden country trials appear

Sign up with your email to follow new studies for HIV-infected participants with latent TB infection in high TB burden country, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Four weeks vs twelve weeks: can a shorter TB prevention course work?

Prevention Ongoing

Researchers are testing whether a 4-week daily course of isoniazid and rifapentine can prevent active tuberculosis as well as the standard 12-week weekly course in people with HIV who have latent TB infection. The trial enrolls about 2,500 adults in a high TB burden country. Both…

Matched conditions: HIV-INFECTED PARTICIPANTS WITH LATENT TB INFECTION IN HIGH TB BURDEN COUNTRY

Phase 3 • Sponsor: The HIV Netherlands Australia Thailand Research Collaboration • Aim: Prevention

Last updated Sep 18, 2026 00:00 UTC

HIV-infected participants with latent TB infection in high TB burden country

Get alerted when new HIV-infected participants with latent TB infection in high TB burden country trials appear

Four weeks vs twelve weeks: can a shorter TB prevention course work?